DOR/3TC
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for DOR/3TC, covering 2025-06-11 to 2025-06-11. Get the full timeline:
Most recent: Clinical Trial Update: Doravirine/Lamivudine (DOR/3TC) as a Maintenance ART in Comparison With Dolutegravir/Lamivudine (DTG/3TC) in PLWH Successfully [Phase 2]